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Abstract The study aimed to evaluate urogenital symp-
toms, defecatory symptoms and quality of life before and
after a sacrospinous hysteropexy for uterovaginal prolapse.
Seventy-two women with symptomatic uterovaginal pro-
lapse were treated with sacrospinous hysteropexy. Before
and after surgery, urogenital and defecatory symptoms and
quality of life were assessed with a validated questionnaire.
Anatomical outcome was assessed by means of pelvic
examination before and after surgery. The mean follow-up
time was 12.7 months. Scores on all domains of urogenital
symptoms and defecatory symptoms, except for the pain
and fecal incontinence domain, improved significantly.
Also, quality of life improved on all domains. No major
complications were encountered.
Keywords Pelvicorganprolapse.Sacrospinous
hysteropexy.Functionaloutcome.Qualityoflife
Introduction
In the current debate on the optimal surgical treatment of a
uterine descent, several vaginal and abdominal techniques
have been described. In case of a vaginal vault prolapse, the
sacrospinous ligament fixation has proven to be an effective
treatment [1]. The sacrospinous ligament fixation can also
be performed as primary treatment for a uterine descent, a
technique that can be referred to as ‘sacrospinous hyster-
opexy’. This procedure has been described in women who
wanted to preserve the uterus to retain fertility [2, 3].
Several studies have shown that the sacrospinous hyster-
opexy is anatomical efficient and safe and most women are
highly satisfied about the procedure [4–10]. Outcome in
these studies was mainly assessed in terms of anatomical
results, and the majority of these studies did not evaluate
urogenital symptoms and quality of life with validated
questionnaires. So, although anatomical outcome of the
sacrospinous hysteropexy appears to be good, we cannot
conclude from current literature that this type of surgery is
associated with a significant functional improvement of
urogenital and defecatory symptoms. Measuring this func-
tional outcome preoperatively and postoperatively was one
of the recommendations for future research from a recent
review on the subject [11]. The main objective of this study
was to assess urogenital and defecatory symptoms and
quality of life before and after sacrospinous hysteropexy.
Secondary, we assessed anatomical outcome.
Materials and methods
Patients
In the period between December 2001 and April 2005, 72
women underwent a sacrospinous hysteropexy at the
University Medical Center Utrecht, The Netherlands.
A woman was eligible for participation if she had a
symptomatic pelvic organ prolapse and wanted surgical
correction with preservation of the uterus. Exclusion criteria
were abnormal uterus or ovaries on ultrasound examination,
abnormal bleeding pattern and abnormal cervical cytology.
All women answered a standardized questionnaire covering
urogenital symptoms, defecatory symptoms and quality of
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proved by the local ethics committee.
Surgery
Surgery was performed by two experienced surgeons who
at least had performed 20 sacrospinous hysteropexies
before start of the study. The sacrospinous hysteropexy
was performed unilaterally to the right ligament. A midline
incision in the posterior vaginal wall is extended to the
posterior part of the cervix. Through sharp and blunt
dissection, the right sacrospinous ligament is made visible
with the use of three Breisky retractors. Two non-
absorbable Prolene® sutures (Ethicon, Sommerville, NJ,
USA) are placed through the right sacrospinous ligament,
approximately 2 cm median to the ischial spine, and
subsequently placed through the posterior side of the cervix
in the midline. An additional anterior and/or posterior
colporrhaphy (fascia plication), with absorbable Vicryl® 2-
0 interrupted sutures (Ethicon, Sommerville, NJ, USA), was
performed when indicated by the judgment of the individ-
ual gynecologist. In case of stress urinary incontinence,
confirmed by urodynamic tests, a surgical procedure of the
Tension-free Vaginal Tape (TVT, Ethicon, Sommerville,
NJ, USA) was performed as described by Ulmsten [12]. All
women received peri-operative thrombosis prophylaxis
(anti-Xa) and a single dose of intravenous prophylactic
antibiotic (amoxicillin/clavunalic acid). Post-operatively, a
14-French Foley indwelling bladder catheter with a 5-ml
balloon was placed in all women and removed after 1 day
(in case of an additional anterior colporrhaphy after 3 days).
Measurements
Data collection took place in October/September 2005, at
least 3 months after surgery of the last participating woman.
The following data were collected: age at the time of
surgery; medical history; hospital stay and perioperative
and postoperative complications. The anatomical outcome
of all women was assessed with the Pelvic Organ Prolapse
Quantification score (POP-Q) [13], which is described by
the International Continence Society as a reliable and
specific method to measure the pelvic organ support.
Before surgery, POP-Q was performed by one of the two
surgeons. After surgery, POP-Q was performed by one of
three independent investigators. In the analysis, we dichot-
omized the POP-Q stage of prolapse into stage 1 or less and
stage 2 or higher. Although we know that women with
pelvic organ prolapse experience symptoms that do not
necessarily correlate with the severity of prolapse, we have
chosen this approach to try to separate potential clinical
irrelevant from clinical relevant recurrences [14].
Urogenital symptoms were measured before and after
surgery with a standardized questionnaire, the Urogenital
Distress Inventory (UDI), which has been validated for
the Dutch population [15]. In this validation study on a
large population-based sample, it was shown that the
domain construction of the Dutch version was different
from the original one. The following five domains were
identified: urinary incontinence, overactive bladder, pain,
obstructive micturition and prolapse. The scores of these
domains vary between 0 and 100. A high score on a
particular domain indicates more bothersome symptoms.
The incidence of urinary incontinence before surgery was
measured as follows: a woman was considered to have
stress urinary incontinence if she replied positively to the
question “Do you experience urinary leakage related to
physical activity, coughing or sneezing?”. Urge urinary
incontinence was scored if the question, “do you experience
urinary leakage related to the feeling of urgency?” was
answered positively.
All patients completed a questionnaire, the Defecatory
Distress Inventory (DDI) to assess the presence of
defecation symptoms before and after surgery. This ques-
tionnaire was developed by our research group to assess the
presence of defecation symptoms [16]. The DDI consists of
15 items about symptoms related to obstructive defecation,
constipation, fecal incontinence and pain related to defeca-
tion. The questions were developed after studying the
literature and international definitions, interviewing patients
who presented with constipation or fecal incontinence, and
by interviewing three experts in the field from the
Department of Surgery and Department of Obstetrics and
Gynecology from the University Medical Center Utrecht,
The Netherlands. Eventually, a structured interview of the
15 selected items was held with 20 female patients. The
DDI was used as, at present, there are no other Dutch
validated questionnaires to measure quality of life related to
defecation symptoms. The design on the questions is
identical to those of the UDI with domain scores between
0 and 100. Again, a high score on a particular domain
indicates more bothersome symptoms. The DDI was used
in previous studies at our department [4, 9, 17].
Before and after surgery, disease-specific quality of life
was measured with the Incontinence Impact Questionnaire
(IIQ), validated for the Dutch population [15]. These
questions cover the following five domains: physical
functioning, mobility, emotional functioning, social func-
tioning and embarrassment. The score ranged between 0
(best quality of life) and 100 (worst quality of life).
Effect sizes were measured as a useful way to estimate
whether an improvement on a particular domain was
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Statistical analysis
Descriptive statistics were used for the whole population.
To compare scores on urogenital and defecatory symptoms
before and after surgery a paired samples t test was used.
The significance level was set at α of 0.05. The effect size
was calculated by Cohen’s d test which is defined as the
difference between two means divided by the pooled
standard deviation for those means [18]. An effect size of
0.2 was considered to be small, 0.5 to be median and 0.8 or
higher to be large [18]. Statistical analysis was performed in
SPSS 12.0 for Windows.
Results
Table 1 shows the characteristics of the 72 women. The fast
majority had a combination of sacrospinous hysteropexy
with an anterior colporrhaphy (87.5%). Five women (6.9%)
had a sacrospinous hysteropexy of a stage 1 uterine descent.
In these women, the surgeon decided to perform a
sacrospinous hysteropexy during surgery because the
uterine descent under anaesthesia was stage 2. The mean
follow-up time was 12.7 months (median 11 months).
Perioperative and postoperative complications are shown
in Table 2. One woman needed repeated surgery for
postoperative bleeding a couple of hours after the primary
procedure. Total blood loss was estimated at 400 cc. There
were no incidental bladder or rectal injuries. Of the 20
women (27.8%) who had urinary retention over 100 ml
after removal of the indwelling bladder catheter, five
women (6.9%) needed intermittent self-catheterisation more
than 2 weeks after surgery. However, at 4 weeks, no women
had significant urinary retention. This complication only
occurred in women who underwent an anterior colpor-
rhaphy. Seven women with cystitis received antibiotics and
made an uneventful recovery. Five women (6.9%) devel-
oped right-sided buttock pain which persisted longer than
2 weeks. It resolved spontaneously within 6 weeks. No
removal of the sacrospinal suture was required.
During the follow-up period, a total of 16 women
(22.2%) had a recurrent prolapse of one of the compart-
ments. Five women (6.9%) had a recurrent prolapse of the
uterus (four women stage 2, one woman stage 3). Ten
women (13.9%) had a cystocele stage 2 or more (eight
women stage 2, two women stage 3) and two women
(2.8%) had a prolapse of the posterior compartment stage 2.
All the women with a recurrent cystocele had had surgery
of the anterior compartment combined with the hystero-
pexy, so there were no de novo cystoceles. The two women
with a recurrent rectocele did not have surgery of the
posterior compartment combined with the sacrospinous
hysteropexy, so these can be considered as de novo
rectoceles.
Table 1 Patient characteristics
Patient characteristics n=72
Age (years)
a 57.2 (11.9)
Surgery for prolapse in medical history 3 (4.2)
Surgery for urinary incontinence in
medical history
4 (5.6)
Urinary incontinence before surgery
b 40 (55.6)
Urge incontinence 9 (12.5)
Stress incontinence 21 (29.2)
Combination stress and urge incontinence 10 (13.9)
Gynecological examination before surgery
Descensus uteri stage 2 or more 67 (93.2)
Cystoceles stage 2 or more 57 (79.2)
Rectoceles stage 2 or more 19 (26.4)
Enterocele 1 (1.4)
Surgery
Sacrospinous hysteropexy 8 (11.1)
Sacrospinous hysteropexy + anterior
colporrhaphy
54 (75)
Sacrospinous hysteropexy + anterior
and posterior colporrhaphy
9 (12.5)
Sacrospinous hysteropexy + posterior
colporrhaphy
1 (1.4)
Additional TVT 15 (20.8)
Hospital stay (days)
c 3.5 (1–8)
Follow-up in months
c 12.7 (3–33)
Data are numbers (%)
aMean (standard deviation)
bAssessed with Urogenital Distress Inventory
cRange
Table 2 Complications related to surgery
Patient characteristics n=72
Complications during surgery 0 (0)
Complications after surgery 32 (44.4)
Second surgery because of bleeding 1 (1.4)
Buttock pain 13 (18.1)
Buttock pain <2 weeks 8 (11.1)
Buttock pain >2 weeks 5 (6.9)
Vaginal hematoma 2 (2.8)
Urinary tract infection 7 (9.7)
Retention bladder 20 (27.8)
Bladder catheterisation <2 weeks 15 (20.8)
Bladder catheterisation >2 weeks 5 (6.9)
Vaginal adhesion 3 (4.2)
Data are numbers (%)
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domain scores before and after surgery. On all urogenital
domains, there was significant improvement as well as on all
quality of life domains. Symptoms on domain constipation
and obstructive defecation also improved significantly.
Large effect sizes were found on domain pain (effect size=
0.92) and genital prolapse (effect size=2.0) of the UDI. The
domain physical functioning and emotional health of the IIQ
also showed a large effect size (0.82 and 0.79, respectively).
In addition to the table we made a sub-analysis for the 15
women who had additional surgery for urinary incontinence
(TVT). These women improved significantly on the urinary
incontinence domain after surgery (mean score: 26.7→6.7,
p=0.009). This improvement was not significant for the
women without TVT surgery (mean score: 16.4→11.5, p=
0.162). On the other hand, the women with TVT surgery did
not improve significantly on the overactive bladder domain
(mean score: 24.3→16.23, p=0.079) where the group
without TVT did (mean score: 30.8→14.3, p=0.000).
Discussion
The objective of this study was to assess quality of life and
urogenital and defecatory symptoms before and after
sacrospinous hysteropexy. The results show that a sacro-
spinous hysteropexy significantly reduced all urogenital
and several defecatory symptoms and significantly im-
proved quality of life. Effect sizes were large on domain
genital prolapse and pain (UDI), and on domain physical
functioning and emotional health (IIQ). It also anatomically
cured the uterine descent in 93.1% of women.
The sacrospinous ligament fixation was first described
by Sederl (1958) [19]. Later it became more popular by
Richter and Albright [20]( E u r o p e )a n dR a n d a l la n d
Nichols [21, 22] (USA). Several modifications of their
techniques have been described since. The anatomical
results of 2,256 women after a sacrospinous ligament
fixation of the vaginal vault were recently reviewed [1].
Objective cure rates varied between 67 and 96.8%, and
subjective cure rates varied between 70 and 98%. Our
findings are in line with these results, although the review
focused on the sacrospinous fixation of a vault prolapse.
Subjective outcomes are underreported in most studies on
the sacrospinous ligament fixation. We have shown
prospectively that bladder and bowel function improves
significantly after a sacrospinous hysteropexy.
There are a variety of reasons why women want to
preserve their uterus. Among those reasons are: keeping
their fertility, personal identity, but also the possibility that
this kind of surgery might reduce operation time, estimated
blood loss and postoperative recovery time [4, 23]. There
are signs that removing the uterus may increase the risk of
pelvic neuropathy, new onset urinary incontinence, bladder
dysfunction and prolapse [24, 25, 26]. Several studies on
the sacrospinous hysteropexy, as a technique in which the
uterus is preserved, are available [3–6, 8–10, 27]. Among
these studies, three were of prospective design [6, 8, 27],
five were of retrospective design [3–5, 9, 10] and there was
one case report [28]. One report described a different
surgical technique and therefore cannot be compared with
our study [2]. One study assessed risk factors for failure of
sacrospinous hysteropexy [29] and another study only
assessed sexual functioning after sacrospinous hysteropexy
[30]. Anatomic success rates in these studies varied
between 74 and 93.5%, which is comparable with our
results. The main problems when comparing studies on the
sacrospinous ligament fixation were recently debated by
Table 3 Urinary Distress In-
ventory (UDI), Defecatory
Distress Inventory (DDI) and
Incontinence Impact
Questionnaire (IIQ)
Effect size: 0.2 = small effect,
0.5 = median effect, 0.8 = large
effect
aMean (standard deviation)
Before surgery
a (n=72) After surgery
a (n=72) P value Effect size
UDI
Urinary incontinence 18.5 (24.2) 10.5 (21.0) 0.012 0.35
Overactive bladder 29.5 (26.7) 14.4 (18.6) 0.000 0.66
Pain 30.1 (26.7) 9.5 (16.7) 0.000 0.92
Obstructive micturition 27.0 (28.3) 10.8 (19.7) 0.000 0.66
Genital prolapse 56.6 (32.0) 5.6 (17.4) 0.000 2.0
DDI
Constipation 11.9 (18.8) 6.3 (9.8) 0.021 0.37
Obstructive defecation 13.3 (19.7) 8.3 (11.8) 0.016 0.22
Pain 4.5 (16.3) 2.8 (8.3) 0.498 0.13
Fecal incontinence 8.6 (20.7) 8.5 (14.4) 0.955 0.01
IIQ
Physical functioning 26.0 (24.4) 9.4 (15.1) 0.000 0.82
Mobility 25.0 (22.8) 12.6 (18.4) 0.000 0.60
Emotional health 23.2 (23.3) 8.0 (14.2) 0.000 0.79
Social functioning 14.8 (19.1) 4.5 (11.8) 0.000 0.65
Embarrassment 11.2 (13.8) 6.7 (11.1) 0.013 0.41
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definition of failure of sacrospinous ligament fixation due
to differences in how anatomical outcomes are evaluated
and which compartment of the vagina is considered. In our
group, recurrent postoperative cystoceles, stage 2 or higher,
were seen in 10 women (13.9%). This percentage is slightly
lower than the 21.3% reported in the recent review [11].
However, our follow-up in the current study was relatively
short and some recurrences may not have been detected in
this timeframe.
. In a previous retrospective study on the
anatomical outcome of the sacrospinous hysteropexy by our
group, we found a higher rate of recurrent cystoceles stage
2 or higher (30%) [9]. The follow-up period in this study
was a mean of 23 months. The high rate of recurrent
cystoceles may be related to the primary damage of
neuromuscular support or may be the result of the
retroverted axis of the vagina after sacrospinous hyster-
opexy. This last aspect, being regarded as an overcorrec-
tion, is held responsible for the high rate of cystoceles [27,
31]. However, in a study by Smilen et al. [32]t h e
sacrospinous hysteropexy did not independently increase
the risk of recurrent cystocele as compared to other surgical
techniques.
Apart from true genital prolapse symptoms, urogenital
symptoms and also bowel symptoms improved after the
sacrospinous hysteropexy. Because the majority of women
in our study had their sacrospinous hysteropexy combined
with an anterior colporrhaphy, one may argue that it was
this anterior repair that relieved symptoms, and not the
sacrospinous hysteropexy. However, it was shown that
pelvic organ prolapse and urogenital symptoms were only
slightly correlated to the site and severity of the prolapse
[14]. This lack of a clear correlation between the site of the
pelvic organ prolapse and symptomatology makes it very
difficult in combination surgery to contribute functional
improvement to a certain intervention. All we can conclude
from our results is that surgical procedures that involve a
sacrospinous hysteropexy show good functional outcome.
It was shown that overactive bladder symptoms disap-
pear after anterior repair in 60–82% of women [33]. We
also found a marked improvement of overactive bladder
symptoms after surgery in our group. However, this
significant improvement was confined to the women who
did not have a combined TVT procedure with their
sacrospinous hysteropexy. Women who did have a TVT
combined procedure experienced more bother on overactive
bladder domain after surgery as compared to women
without TVT surgery. This finding is consistent with
literature on the TVT in which the development of
overactive bladder symptoms after TVT surgery is reported
to occur in up to 15% of women [34].
We have to keep this in mind when placing a TVT
(prophylactic) in case of occult stress incontinence. After
sacrospinous hysteropexy, postoperative complications oc-
cur, but none of them was life threatening. Most compli-
cations were self-limiting. The majority of postoperative
complications were related to the bladder function. These
complications did not occur in women who only had a
sacrospinous hysteropexy. Therefore, it is likely that
complications related to the bladder are the consequence
of additional surgery and not the result of sacrospinous
hysteropexy. The prevalence of buttock pain is estimated at
10 to 15% [35]. This pain can be explained by injury to
surrounding nerves of the sacral plexus and branches of the
pudendal nerve. In an anatomical study, the relationship of
the pudendal nerve to the sacrospinous ligament was found
to be variable (one branch of the pudendal nerve piercing
through the ligament was found in 11%) [36]. Barksdale et
al. also showed that nerve tissue is present and widely
distributed within the sacrospinous ligament [37]. There-
fore, although the placement of the suture two centimetres
medial to the ischial spine protects against major nerve
injuries, the complications of buttock pain cannot be
prevented in all women. Fortunately, this buttock pain
was shown to resolve spontaneously in most cases, as we
also demonstrated in our series [9].
The strength of our study is that we measured urogenital
and defecatory symptoms and quality of life in a large
group of women who underwent a sacrospinous hyster-
opexy, with a validated questionnaire before and after
surgery. There are some potential drawbacks that need to be
discussed. First, there might be an indication bias. In our
country, a vaginal hysterectomy is the standard surgical
technique for correcting a uterine descent. Therefore,
women that came to our hospital may have chosen
specifically for this operation. They might have had high
expectations of this procedure which could have influenced
their outcome with respect to quality of life. Second, in
some patients, follow-up time was limited to 3 months.
Possibly, some recurrences had not yet developed at that
time. Third, the study was performed in a single university
hospital. The sacrospinous ligament fixation has become
rapidly popular in our center and is performed by two
surgeons. They are highly trained in performing the
procedure. This might have influenced the outcome. Fourth,
we did not compare the sacrospinous hysteropexy with
another surgical technique to correct a uterine descent.
Therefore, we cannot conclude that the sacrospinous
hysteropexy is superior to other procedures. However, it is
a safe and effective operation for women who wish to
preserve their uterus at time of genital prolapse surgery.
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